We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+71.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$431M
AUM Growth
-$231M
Cap. Flow
-$253M
Cap. Flow %
-58.7%
Top 10 Hldgs %
33.8%
Holding
598
New
119
Increased
47
Reduced
97
Closed
268

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$21.3M
2
WMT icon
Walmart Inc
WMT
+$14.3M
3
RIO icon
Rio Tinto
RIO
+$4.13M
4
J icon
Jacobs Solutions
J
+$3.67M
5
BWA icon
BorgWarner
BWA
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 28.32%
2 Healthcare 13.2%
3 Financials 12.49%
4 Industrials 11.45%
5 Materials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PK icon
301
Park Hotels & Resorts
PK
$3.03B
$185K 0.04%
17,700
INFU icon
302
InfuSystem Holdings
INFU
$189M
$165K 0.04%
18,400
VTRS icon
303
Viatris
VTRS
$20.5B
$156K 0.04%
12,500
-11,300
-47% -$122K
MNKD icon
304
MannKind Corp
MNKD
$1.25B
$154K 0.04%
27,235
REI icon
305
Ring Energy
REI
$302M
$147K 0.03%
168,500
PBI icon
306
Pitney Bowes
PBI
$2.46B
$133K 0.03%
+12,600
New +$131K
WEN icon
307
Wendy's
WEN
$1.41B
$130K 0.03%
15,600
CCC
308
CCC Intelligent Solutions
CCC
$3.53B
$124K 0.03%
15,630
BGS icon
309
B&G Foods
BGS
$289M
$121K 0.03%
28,200
NFBK
310
DELISTED
Northfield Bancorp
NFBK
$117K 0.03%
10,200
QIPT
311
DELISTED
Quipt Home Medical
QIPT
$112K 0.03%
31,845
NUS icon
312
Nu Skin
NUS
$253M
$111K 0.03%
11,585
NGD
313
DELISTED
New Gold Inc
NGD
$109K 0.03%
+12,500
New +$94.1K
MRAM icon
314
Everspin Technologies
MRAM
$346M
$107K 0.02%
11,570
LCTX icon
315
Lineage Cell Therapeutics
LCTX
$254M
$104K 0.02%
62,400
RC
316
Ready Capital
RC
$270M
$99.8K 0.02%
+45,800
New +$128K
SITC icon
317
SITE Centers
SITC
$236M
$89.2K 0.02%
+13,900
New +$105K
CCCC icon
318
C4 Therapeutics
CCCC
$391M
$81.2K 0.02%
42,500
BTG icon
319
B2Gold
BTG
$5.16B
$79.4K 0.02%
17,600
-65,200
-79% -$304K
LAC
320
Lithium Americas
LAC
$1B
$73.7K 0.02%
+16,900
New +$97.6K
THRY icon
321
Thryv Holdings
THRY
$179M
$66.5K 0.02%
+11,000
New +$87.1K
ABOS icon
322
Acumen Pharmaceuticals
ABOS
$160M
$62.5K 0.01%
29,600
JBLU icon
323
JetBlue
JBLU
$2.03B
$54.1K 0.01%
+11,900
New +$54.3K
NMRA icon
324
Neumora Therapeutics
NMRA
$293M
$53K 0.01%
29,600
LXRX icon
325
Lexicon Pharmaceuticals
LXRX
$1.04B
$46.3K 0.01%
40,300

Similar funds

Catalyst Funds Management's Q4 2025 Portfolio in Review

As of Q4 2025, Catalyst Funds Management held 598 positions worth $431M, down 35% from $662M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Catalyst Funds Management withdrew a net $253M in Q4 2025, closing 268 positions and reducing 97 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Catalyst Funds Management opened a new position in Walmart Inc worth $14.8M.

  • Catalyst Funds Management's largest Q4 2025 buy was Walmart Inc: 133,200 shares worth $14.8M.
  • Catalyst Funds Management added most to Broadcom in Q4 2025, an estimated $21.3M increase.
  • Catalyst Funds Management's biggest Q4 2025 reduction was Apple, cutting an estimated $22.3M.
  • Catalyst Funds Management fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $22.6M.
  • Catalyst Funds Management's ten largest holdings make up 34% of its $431M portfolio in Q4 2025.
  • Catalyst Funds Management opened 119 new positions and closed 268 in Q4 2025.
  • Catalyst Funds Management's portfolio value fell 35% quarter-over-quarter to $431M.

Based on Catalyst Funds Management's 13F filing for Q4 2025, filed 9 Feb 2026.